Medicare Enrolled
Dr. Ryan Moody, M.D
Pulmonary Disease · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moody from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moody?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moody
Dr. Ryan Moody is a pulmonary disease specialist in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Moody performed 4,296 Medicare services across 3,427 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moody received a total of $31,603 from 56 pharmaceutical and/or device companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moody is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in GA
$31,603 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,296
Medicare services
Top 2% in GA for pulmonary disease
3,427
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
960 | $88 | $138 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
456 | $59 | $111 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
405 | $29 | $44 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
405 | $37 | $61 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
343 | $18 | $37 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
202 | $27 | $47 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
188 | $34 | $55 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
149 | $86 | $126 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
135 | $129 | $187 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $113 | $183 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
101 | $158 | $289 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
92 | $36 | $55 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
91 | $53 | $150 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
86 | $24 | $33 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
77 | $27 | $30 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
70 | $14 | $16 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
67 | $30 | $48 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $76 | $112 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
47 | $97 | $151 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $62 | $85 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
41 | $100 | $265 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
37 | $415 | $599 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
24 | $14 | $21 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $120 | $269 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
20 | $107 | $210 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
18 | $12 | $16 |
| New patient office visit, complex (60-74 min) | 18 | $142 | $225 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
14 | $422 | $701 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$31,603
Total received (2018-2024)
Avg $4,515/year across 7 years
Top 7% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
790
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,329 (54.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,274 (45.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,053
2023
$12,372
2022
$2,715
2021
$1,222
2020
$1,336
2019
$1,423
2018
$1,483
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,422
Regeneron Healthcare Solutions, Inc.
$574
AstraZeneca Pharmaceuticals LP
$400
Merck Sharp & Dohme LLC
$382
GENZYME CORPORATION
$350
United Therapeutics Corporation
$340
GlaxoSmithKline, LLC.
$316
Axsome Therapeutics, Inc.
$197
Amgen Inc.
$162
Insmed, Inc.
$138
Grifols USA, LLC
$95
Inspire Medical Systems, Inc.
$93
SANOFI-AVENTIS U.S. LLC
$79
Pulmonx Corporation
$78
HARMONY BIOSCIENCES LLC
$75
Takeda Pharmaceuticals U.S.A., Inc.
$55
Mylan Specialty L.P.
$52
Mallinckrodt Hospital Products Inc.
$50
Electromed, Inc.
$41
Actelion Pharmaceuticals US, Inc.
$40
ABIOMED
$31
JAZZ PHARMACEUTICALS INC.
$28
Fisher & Paykel Healthcare Inc
$24
Vifor Pharma, Inc.
$17
Avadel CNS Pharmaceuticals, LLC
$15
Top 3 companies account for 76.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,490
GlaxoSmithKline, LLC.
$2,138
AstraZeneca Pharmaceuticals LP
$1,564
Regeneron Healthcare Solutions, Inc.
$1,296
Actelion Pharmaceuticals US, Inc.
$1,057
Insmed, Inc.
$813
United Therapeutics Corporation
$737
GENZYME CORPORATION
$720
Merck Sharp & Dohme LLC
$580
Axsome Therapeutics, Inc.
$436
Amgen Inc.
$335
Mallinckrodt Hospital Products Inc.
$334
Electromed, Inc.
$322
Harmony Biosciences LLC
$300
Inspire Medical Systems, Inc.
$283
JAZZ PHARMACEUTICALS INC.
$271
Genentech USA, Inc.
$258
Mylan Specialty L.P.
$251
Allergan Inc.
$215
Sunovion Pharmaceuticals Inc.
$183
Circassia Pharmaceuticals Inc
$162
Novartis Pharmaceuticals Corporation
$147
HARMONY BIOSCIENCES LLC
$137
Grifols USA, LLC
$126
Janssen Pharmaceuticals, Inc
$119
Baxter Healthcare
$94
Fisher & Paykel Healthcare Inc
$94
Bayer HealthCare Pharmaceuticals Inc.
$91
Jazz Pharmaceuticals Inc.
$82
SANOFI-AVENTIS U.S. LLC
$79
Pulmonx Corporation
$78
Merck Sharp & Dohme Corporation
$76
Takeda Pharmaceuticals U.S.A., Inc.
$75
Alexion Pharmaceuticals, Inc.
$74
Covidien LP
$66
Shionogi Inc
$53
IDORSIA PHARMACEUTICALS US INC
$47
Eisai Inc.
$45
PFIZER INC.
$42
ABIOMED
$31
Inogen, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
Mallinckrodt Enterprises LLC
$25
ANI Pharmaceuticals, Inc.
$25
Astellas Pharma US Inc
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Pharming Healthcare, Inc.
$18
La Jolla Pharmaceutical Company
$18
Vifor Pharma, Inc.
$17
Shire North American Group Inc
$17
Inari Medical, Inc.
$17
Avadel CNS Pharmaceuticals, LLC
$15
Avanir Pharmaceuticals, Inc.
$15
Philips Electronics North America Corporation
$13
Allergan, Inc.
$11
bioMerieux
$10
Top 3 companies account for 67.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Andexxa · Arikayce · BELSOMRA · BOSENTAN TABLETS · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · Cresemba · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · ELIQUIS · ENTRESTO · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · Fetroja · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN · INSPIRE · Impella · Inspire Upper Airway Stimulation System · JANUVIA · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · NEPHROCHECK TEST · NIOX VERO · NUCALA · NUEDEXTA · OFEV · OPSUMIT · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PT100US/myAIRVO 2 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C Liquid · QUVIVIQ · RUCONEST · Respiratoriy Care Undiv · S · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · SuperDimension · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Ultomiris · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pulmonary disease in GA.
Geographic Context
Pulmonary diseases within 10 mi
15
Per 100K population
5.0
County median income
$69,575
Nearest hospital
ST JOSEPH'S HOSPITAL - SAVANNAH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moody is a clinical cardiology specialist, with above-average Medicare volume (top 2% in GA), with speaking/promotional industry engagement in the top 7% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moody experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Moody performed 960 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moody receive payments from pharmaceutical companies?
Yes. Dr. Moody received a total of $31,603 from 56 companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moody's costs compare to other pulmonary diseases in Savannah?
Dr. Moody's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moody) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Savannah
Browse pulmonary diseases in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology